Somai logo.png
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland
12 juin 2023 01h00 HE | SOMAÍ Pharmaceuticals
LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered into a two-year supply agreement with a well-respected Polish distributor Cosma...
vol_botanicals_logo.png
Tennessee General Assembly Passes Sweeping Regulations for Hemp-Derived Cannabinoids
02 mai 2023 07h00 HE | Volunteer Botanicals
MURFREESBORO, Tenn., May 02, 2023 (GLOBE NEWSWIRE) -- The most substantive cannabis regulatory legislation in Tennessee history will soon become law, creating critical regulations on producing,...
Delvens globenewswire jpg-1200x628.jpg
Cannabidiol Market Size 2023-2030: Global Analysis by Type, Product, Sales, Region, Competitive Landscape, End-Use Outlook, Overview, Supply and Demand Side Analysis
24 avr. 2023 15h34 HE | Delvens
City of Boardman, April 24, 2023 (GLOBE NEWSWIRE) -- The global market for Cannabidiol is expected to reach $4.14 billion by 2030 from $1.92 billion in 2021, registering impressive expansion at a...
vol_botanicals_logo.png
Volunteer Botanicals Joins with Cultivate Tennessee in Effort to Regulate Hemp-Derived Cannabinoids
23 févr. 2023 09h08 HE | Volunteer Botanicals
MURFREESBORO, Tenn., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Volunteer Botanicals, which develops consistent, versatile hemp-based cannabinoid ingredients for use in a wide variety of consumer products,...
vol_botanicals_logo.png
Volunteer Botanicals Launches Line of Wellness Products Created with Plant-based Ingredients
21 févr. 2023 07h00 HE | Volunteer Botanicals
MURFREESBORO, Tenn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Volunteer Botanicals, which develops consistent, versatile hemp-based cannabinoid ingredients for use in a wide variety of consumer products,...
Linnea Cannabinoids Logo.png
Linnea SA Receives Swiss Narcotics License allowing for the Production and Exportation of High THC Active Pharmaceutical Ingredients
16 janv. 2023 05h00 HE | Linnea
RIAZZINO, Switzerland, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Linnea SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics...
vol_botanicals_logo.png
Volunteer Botanicals’ Satival Cannabinoid Powders Demonstrate Potential in Clinical Study
10 janv. 2023 16h35 HE | Volunteer Botanicals
MURFREESBORO, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Volunteer Botanicals, which develops consistent, versatile hemp-based cannabinoid ingredients for use in a wide variety of consumer products,...
InMed Pharmaceuticals Inc..jpg
InMed Provides Business Update and Milestones for 2023
10 janv. 2023 07h30 HE | InMed Pharmaceuticals Inc.
Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023Progress preclinical research in glaucoma in preparation for human trialsAdvance research using rare cannabinoids in...
GPOPlus+ Assigned Exclusive Trademark License Agreement for the Creation of Yuengling’s Ice Cream Flavored CBD + Cannabinoid Products
GPOPlus+ Assigned Exclusive Trademark License Agreement for the Creation of Yuengling’s Ice Cream Flavored CBD + Cannabinoid Products
12 déc. 2022 09h15 HE | GPO PLUS INC.
Las Vegas, NV and Atlanta, GA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- GPO Plus, Inc. (OTCQB: GPOX), a brand creation and distribution company focused on independent and regional retailers with an ever...
Dyadic Logo Current.jpg
Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments
10 nov. 2022 16h00 HE | Dyadic International, Inc.
Received regulatory approval from South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 clinical trial to demonstrate clinical safety and antibody response in humans for...